Results 161 to 170 of about 2,002,341 (191)

Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis

Journal of Vascular and Interventional Radiology, 2019
PURPOSE: To retrospectively assess the efficacy and safety of radioembolization with yttrium-90 ( MATERIALS AND METHODS: Thirty-three patients with metastatic pancreatic adenocarcinoma that progressed despite systemic chemotherapy and other treatments ...
Alexander Y Kim, Shelby Frantz
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Yttrium-90 Radioembolization for Metastatic Colorectal Cancer

2022
Ching-Wei D Tzeng, Steven Y Huang, Armeen Mahvash   +2 more
exaly   +2 more sources

Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma

CardioVascular and Interventional Radiology, 2017
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare mixed cell type primary liver cancer with limited data to guide management. Transarterial radioembolization with yttrium-90 microspheres (RE) is an emerging treatment option for both hepatocellular carcinoma and intrahepatic cholangiocarcinoma. This study explored the safety and efficacy of
Lauren S, Chan, Daniel Y, Sze, George A, Poultsides, John D, Louie, Mohammed A, Abdelrazek Mohammed, David S, Wang   +5 more
openaire   +2 more sources

Urinary Excretion of Yttrium-90 after Radioembolization with Yttrium-90-Labeled Resin-based Microspheres

Health Physics, 2018
In radioembolic therapy (RET) of hepatic malignancies using yttrium-90 (Y)-labeled resin microspheres, radiation protection is primarily concerned with avoiding contamination by radioactive spheres. However, as Y is bound to the microsphere surface by a potentially reversible ion-exchange process, the aim of this study was to assess the extent of the ...
Großer, Oliver Stephan, Ruf, Juri, Pethe, Annette, Kupitz, Dennis, Wissel, Heiko, Benckert, Christoph, Pech, Maciej, Ricke, Jens, Amthauer, Holger   +8 more
openaire   +3 more sources

Intraprocedural Yttrium-90 Positron Emission Tomography/CT for Treatment Optimization of Yttrium-90 Radioembolization

Journal of Vascular and Interventional Radiology, 2014
Radioembolization with yttrium-90 ((90)Y) microspheres relies on delivery of appropriate treatment activity to ensure patient safety and optimize treatment efficacy. We report a case in which (90)Y positron emission tomography (PET)/computed tomography (CT) was performed to optimize treatment planning during a same-day, three-part treatment session ...
Austin C, Bourgeois, Ted T, Chang, Yong C, Bradley, Shelley N, Acuff, Alexander S, Pasciak   +4 more
openaire   +2 more sources

Yttrium 90 Radioembolization for Hepatocellular Carcinoma.

Radiologic technology, 2021
Radioembolization is used to treat hepatocellular carcinoma, a type of liver cancer, by introducing radioactive yttrium 90 (90Y) directly into the hepatic vasculature. This method allows for a high dose of radiation to be delivered to the cancer cells while sparing the surrounding healthy liver tissue.
openaire   +1 more source

Yttrium-90 Radioembolization Complicated by Colitis

Journal of Vascular and Interventional Radiology, 2021
Jai Won Jung, Haley S. Foster, Nora E. Tabori, Gajan Sivananthan   +3 more
openaire   +2 more sources

Yttrium‐90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation

World Journal of Surgery, 2016
AbstractBackgroundLiver transplantation (LT) is a well‐established procedure for hepatocellular carcinoma (HCC) within the Milan criteria. Yttrium‐90 microspheres radioembolization (Y90‐RE) has shown to be an effective and safe treatment of primary liver tumors.
Ettorre GM, Levi Sandri GB, Laurenzi A, Colasanti M, Meniconi RL, Lionetti R, Santoro R, Lepiane P, Sciuto R, Pizzi G, Cianni R, Golfieri R, D’Offizi G, Pellicelli AM, Antonini M, Vennarecci G   +15 more
openaire   +3 more sources

Hepatic yttrium-90 radioembolization for metastatic melanoma

Melanoma Research, 2014
The aim of the study was to analyze the safety and efficacy of yttrium-90 ((90)Y) radioembolization in the treatment of unresectable hepatic melanoma metastases refractory to previous systemic/locoregional therapy. Between February 2004 and April 2010, 16 patients with hepatic melanoma metastases (ocular=7, skin=4, other sites=5) were treated with (90 ...
Khairuddin, Memon, Timothy M, Kuzel, Michael, Vouche, Rohi, Atassi, Robert J, Lewandowski, Riad, Salem   +5 more
openaire   +2 more sources

Yttrium-90 Radioembolization of a Large Hepatic Hemangioma

CardioVascular and Interventional Radiology, 2023
Vikram F. Gupta, James Ronald, Nicholas T. Befera, Brendan C. Cline, Paul V. Suhocki, Charles Y. Kim   +5 more
openaire   +2 more sources